Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail
-

OBRR Lot Release Clearance Memo Email, June 3, 2011 - Kedbumin

From:                     CBER Lot Clearance

Sent:                      Friday, June 03, 2011 2:35 PM
To:                         Shields, Mark; CBER Lot Clearance
Cc:                         Allard, Crystal
Subject:                 RE: OBRR Lot release clearance memo: STN:125384/0 :Kedrion, S.p.A. ADD: 03-Jun-2011
A review of PRB records indicates that there are no pending lots or issues that would affect approval of the stated STN.
 
Thank you,

Joseph Quander III
Chief, Product Release Branch
CBER/OCBQ/DMPQ
(301) 594-6517; (301) 594-6924 (Fax)
 
_____________________________________________
From: Shields, Mark
Sent: Friday, June 03, 2011 2:33 PM
To: CBER Lot Clearance
Cc: Allard, Crystal; Quander III, Joseph
Subject: OBRR Lot release clearance memo: STN:125384/0 :Kedrion, S.p.A. ADD: 03-Jun-2011
 
Please confirm that there are no lots associated with this Application.
 
STN_ No: 125384/0

Lic. #:         1851                             Company: Kedrion, S.p.A..

Product: Albumin (Human)
 
Subm Type:Supplement                      Subtype: Original Application
 
Action Due Date: 03-Jun-2011
 
Short Summary: Original Application for 25% Albumin (human) solution
 
Thanks!
 

Mark A. Shields
Regulatory Project Manager
HFM-380  FDA/CBER
Office of Blood Research and Review
Division of Blood Applications
301-827-6173 fax 301-827-2405
email: mark.shields@fda.hhs.gov
1401 Rockville Pike
Rockville, MD 20852-1448

-
-